Matches in Nanopublications for { ?s ?p "MCP-1 protein expression induced by IFN-gamma and CD40L (24 hours) was significantly decreased by the ERK1/2 MAPK pathway inhibitor, U0126. U0126 treatment at 10 micromol/L significantly reduced IFN- gamma and CD40L-induced MCP-1 protein production, bringing the levels of MCP-1 to baseline." ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- _4 value "MCP-1 protein expression induced by IFN-gamma and CD40L (24 hours) was significantly decreased by the ERK1/2 MAPK pathway inhibitor, U0126. U0126 treatment at 10 micromol/L significantly reduced IFN- gamma and CD40L-induced MCP-1 protein production, bringing the levels of MCP-1 to baseline." provenance.
- _4 value "MCP-1 protein expression induced by IFN-gamma and CD40L (24 hours) was significantly decreased by the ERK1/2 MAPK pathway inhibitor, U0126. U0126 treatment at 10 micromol/L significantly reduced IFN- gamma and CD40L-induced MCP-1 protein production, bringing the levels of MCP-1 to baseline." provenance.
- _4 value "MCP-1 protein expression induced by IFN-gamma and CD40L (24 hours) was significantly decreased by the ERK1/2 MAPK pathway inhibitor, U0126. U0126 treatment at 10 micromol/L significantly reduced IFN- gamma and CD40L-induced MCP-1 protein production, bringing the levels of MCP-1 to baseline." provenance.
- _4 value "MCP-1 protein expression induced by IFN-gamma and CD40L (24 hours) was significantly decreased by the ERK1/2 MAPK pathway inhibitor, U0126. U0126 treatment at 10 micromol/L significantly reduced IFN- gamma and CD40L-induced MCP-1 protein production, bringing the levels of MCP-1 to baseline." provenance.
- _4 value "MCP-1 protein expression induced by IFN-gamma and CD40L (24 hours) was significantly decreased by the ERK1/2 MAPK pathway inhibitor, U0126. U0126 treatment at 10 micromol/L significantly reduced IFN- gamma and CD40L-induced MCP-1 protein production, bringing the levels of MCP-1 to baseline." provenance.
- _4 value "MCP-1 protein expression induced by IFN-gamma and CD40L (24 hours) was significantly decreased by the ERK1/2 MAPK pathway inhibitor, U0126. U0126 treatment at 10 micromol/L significantly reduced IFN- gamma and CD40L-induced MCP-1 protein production, bringing the levels of MCP-1 to baseline." provenance.
- _4 value "MCP-1 protein expression induced by IFN-gamma and CD40L (24 hours) was significantly decreased by the ERK1/2 MAPK pathway inhibitor, U0126. U0126 treatment at 10 micromol/L significantly reduced IFN- gamma and CD40L-induced MCP-1 protein production, bringing the levels of MCP-1 to baseline." provenance.
- _4 value "MCP-1 protein expression induced by IFN-gamma and CD40L (24 hours) was significantly decreased by the ERK1/2 MAPK pathway inhibitor, U0126. U0126 treatment at 10 micromol/L significantly reduced IFN- gamma and CD40L-induced MCP-1 protein production, bringing the levels of MCP-1 to baseline." provenance.